AMYLYX

Serial Number 88319631
Registration 6048913
700

Registration Progress

Application Filed
Feb 28, 2019
Under Examination
Aug 20, 2019
Approved for Publication
Jun 25, 2019
Published for Opposition
Jun 25, 2019
Registered
May 5, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200505)
Due: May 05, 2026 138 days

Trademark Image

AMYLYX

Basic Information

Serial Number
88319631
Registration Number
6048913
Filing Date
February 28, 2019
Registration Date
May 5, 2020
Published for Opposition
June 25, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 5, 2020
Registration
Registered
Classes
005

Rights Holder

Amylyx Pharmaceuticals, Inc.

03
Address
43 Thorndike Street
Cambridge, MA 02141

Ownership History

Amylyx Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Amylyx Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Amylyx Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Cynthia Johnson Walden

USPTO Deadlines

Next Deadline
138 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200505)
Due Date
May 05, 2026
Grace Period Ends
November 05, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
May 5, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
May 5, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 2, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 1, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 10, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 19, 2020 IUAF S USE AMENDMENT FILED Loading...
Mar 9, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 19, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 19, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 19, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 19, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 19, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 19, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 20, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 25, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 25, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 25, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 5, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 16, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 9, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 19, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 4, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases
First Use Anywhere: Jul 31, 2017
First Use in Commerce: Jul 31, 2017

Classification

International Classes
005